February 6, 2015
Join us for the 4th Annual New Horizons Forum
Speeding the development of new therapies and diagnostics for glaucoma patients.
San Francisco, CA
The centerpiece of Glaucoma 360, the New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment. Presented by the Glaucoma Research Foundation, this annual catalyst meeting is designed to bring the essential components together in order to speed the translation of new ideas into clinical practice.

“Glaucoma 360, more than any other meeting I’ve been to, brings together a really diverse group of individuals interested in the care of patients with glaucoma.”
— Louis Cantor, MD, Chairman and Professor, Director of the Glaucoma Service, Indiana School of Medicine, Department of Ophthalmology

“The best meeting to see what is happening in glaucoma from surgery to new drugs and drug delivery systems.”
— Alan S. Crandall, MD, University of Utah

“Glaucoma 360 is one of the most interesting meetings in ophthalmology.”
— Judy Gordon, DVM, ClinReg Consulting Services, Inc.

“The New Horizons Forum provides a unique opportunity to bring together industry, physicians, the financial community and academic and government representatives in a meeting focused solely on glaucoma.”
— Schalon Newton, DM, Santen, Inc.

• Early-stage company CEOs and executives
• Business Development and other representatives from companies that offer pharmaceuticals, devices, drug delivery, and IOP monitoring for glaucoma patients
• Key Opinion Leaders and Leading Ophthalmologists
• Industry Executives
• Venture Capitalists
• Clinical Research Organizations
• Scientific innovators